OUR LOCATION

Dubai, UAE

+91 9977002116

Emergency Call- 24/7 support

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Pharmaceuticals » HPH-990915
  • Global Drug Discovery Market-Technologies, Market share and Industry Forecast to 2024

  • Publish: March 2016 | Report Code: HPH-990915

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

The market for the global drug discovery is highly affected due to the scientific and technological changes and advancements that are continuously taking place around the world. This market contributes highly in the growth of whole pharmaceutical industry as they help in introduction of new drugs. The global drug discovery market is projected to grow impressive during the forecasted period growing at a CAGR of 14.2% during 2016-2023. Adoption of global drug discovery market is driven by following factors: such as rising incidences of chronic diseases, rising demand for novel drug discovery technologies and advancement in field of biotechnology.

There are many forces that drive the global drug discovery market, some of which include the increasing adoption of technology by the researchers in the development of new drugs. The market for HTS (High throughput screening) holds the largest market share, owing to the increased use of the cell based assays and robotics in the parallel screening of the compounds. The increasing geriatric population requires more healthcare facilities and hence demands new drugs to cope up with the various health issues which occur due to aging. The emergence of new diseases such as Ebola and H1N1 swine flu also forces the Pharma companies and research firms to work towards development of newer molecules and target drugs.

The factors the restrain the growth of the global drug discovery market are the slow growth and development of new drugs may hamper the growth of this market. Also, the expiry of patents of the major drugs and the huge cost and time factor that is involved in the drug discovery hamper the growth of the global drug discovery market.

The market is a highly regulated; hence face stringent regulations and approval issues from government authorities. Due to which companies are facing the issue of delayed product launches due to long and expensive approval process.

 

 

Source: OBRC Analysis

The global market for drug discovery has been segmented on the basis of services, science, technology and novel technologies. On the basis of service, market is further sub segmented into:

  • Biological Services
  • Chemical Services
  • Pharmaceutical Services
  • Drug Metabolism and Pharmacokinetics (DMPK) Services

On the basis of science, market is sub segmented into:

  • Proteomics
  • Genomics
  • Bioinformatics


On the basis of technology, market is sub segmented into:

  • QPCR
  • DNA and protein microarrays
  • High-throughput screening
  • Mass spectrometry
  • Laboratory information management systems
  • Microfluidics
  • Gel electrophoresis
  • Chromatography
  • Protein and nucleic acid isolation.
  • Others

On the basis of novel technology, the market is further segmented into:

  • Back scattering interferometry
  • Cantilever array

The market is analysed as tissue screening, gene expression profiling, and genetic surrogate for drug action, target validation technologies, antibody-based technology, combinatorial chemistry, SNP genotyping, biochips and microarrays. Some of the major technologies in the market are HTS (High throughput screening), QPCR, proteomics, laboratory management information system, DNA and protein microarrays, genomics, gel electrophoresis, protein and nucleic acid isolation, mass spectrometry, micro fluids, and chromatography.

drug discovery The revenue for the above service and science segments are specific to the market. however, the total revenue of these segments in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up novel technology segment. Geographically, the market is segmented into

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

North America leads the global market for drug discovery due to the presence of manufacturing and research facilities in the region; also, it is the largest consumer of the branded drugs. This region is most lucrative as large number of leading pharmaceutical companies presence. North America countries such as U.S. and Canada have formulated policies for encouraging investors for research in drug development and discovery.  Asia Pacific market is driven by rise in the number contract research organizations. Asia-pacific is fastest growing region due to the presence of skilled labour at affordable cost, rise in disposable income and favourable government policies are also contributing in the market growth.

The companies in this industry focus more on innovation and introduction of new products, increasing efficiency and productivity. There are many companies that dwell in this market, some if the key market players include:

  • Sanofi
  • Johnson and Johnson
  • AstraZeneca
  • Bayer
  • BohringerIngheliem
  • Pfizer
  • GlaxoSmithKline
  • Eli Lily
  • Albany Molecular Research
  • Charles River Laboratories

Detailed analysis of these companies provided in this report comprises Overview, SCOT Analysis, Product Portfolio, Strategic Initiative and Strategic Analysis.

These companies using various strategies such as merger & acquisition, collaboration, partnership and product launching.  Such as Sanofi and Exscientia collaborated to deal in drug discovery in May 2017. This collaboration is to develop bispecific-small-molecule drugs. Exscientia is an innovative company of artificial intelligence driven drug discovery.

Why to buy the report:

This report will provide you:

  • Provide in detail the different segments which are affecting the global market.
  • Provide you the patent analysis.
  • Identify, understand, and the strength, opportunities, challenges and threats.
  • Provide revenues of major players of the market such as Bayer, Sanofi.
  • Provide you various the regulatory policies which are affecting the global market.







 

How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global market offers the longest chain of market segmentation covering major market segmentation based on service science and technology. Report tracks the major market trends in the global market such as advancement in field of biotechnology, genomics, molecular biology and so on.   For each market segments covered we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the drug discovery industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360-degree analysis, See Saw analysis, and Porter five force model and so on. For the high-level analysis in the report we provide a comparative analysis of historic and current year data. 

Key findings:

  • Increasing adoption of drug discovery technologies such as network security systems and cybersecurity systems is fuelling growth in the global market.
  • North America is anticipated to account the largest revenue share in 2016.
  • Collaboration is the key strategy adopted by the various market players.
  • High throughput screening holds the largest market share due to increasing applications of robotics and cell-based assays.

 

1.       INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

2.       MARKET OVERVIEW

2.1. GLOBAL DRUG DISCOVERY MARKET: EVOLUTION & TRANSITION

2.2. MARKET DEFINITION & SCOPE

2.3. INDUSTRY STRUCTURE

2.4. REGULATORY FRAMEWORK

2.5. TOTAL MARKET ANALYSIS

2.5.1.        TOP 5 FINDINGS

2.5.2.        TOP 5 OPPORTUNITY MARKETS

2.5.3.        TOP 5 COMPANIES

2.5.4.        TOP 3 COMPETITIVE STRATEGIES

2.6. ESTIMATION ANALYSIS

2.7. STRATEGIC ANALYSIS

2.7.1.        INVESTMENT VS. ADOPTION MODEL

2.7.2.        360-DEGREE INDUSTRY ANALYSIS

2.7.3.        PORTERS 5 FORCE MODEL

2.7.4.        SEE-SAW ANALYSIS

2.7.5.        CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.8. COMPETITIVE ANALYSIS

2.8.1.        MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS

2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.9.1.        INVESTMENT OPPORTUNITIES BY REGIONS

2.9.2.        OPPORTUNITIES IN EMERGING APPLICATIONS

2.9.3.        INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3.       MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1.        PREVALENCE OF CHRONIC DISEASES

3.1.2.        TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS

3.1.3.        INCREASING HEALTHCARE EXPENDITURE

3.1.4.        INCREASING DRUG APPROVALS BY GOVERNMENT ORGANIZATION

3.2. MARKET RESTRAINTS

3.2.1.        STRINGENT GOVERNMENT REGULATIONS

3.2.2.        HUGE CAPITAL INVESTMENT WITH LOW PROFIT MARGINS  

3.3. MARKET OPPORTUNITIES

3.3.1.        ENHANCEMENT IN POPULATION OF AFFLUENT PATIENTS

3.3.2.        RISE IN DRUG DISCOVERY OUTSOURCING

3.4. MARKET CHALLENGES

3.4.1.        HIGH AMOUNT OF INVESTMENT

3.4.2.        REQUIRES A LONG TIME SPAN

4.       GLOBAL DRUG DISCOVERY MARKET BY DRUG TYPE

4.1. MARKET DEFINITION AND SCOPE

4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.4. OPPORTUNITY MATRIX

4.5. MARKET SEGMENTATION

4.5.1.        GLOBAL SMALL MOLECULE DRUG MARKET

4.5.1.1.               ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2.               MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

4.5.1.3.               KEY PLAYERS & KEY PRODUCTS

4.5.1.4.               KEY CONCLUSIONS

4.5.2.      GLOBAL BIOLOGICS DRUG MARKET

4.5.2.1.               ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.2.2.               MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

4.5.2.3.               KEY PLAYERS & KEY PRODUCTS

4.5.2.4.               KEY CONCLUSIONS

5.       GLOBAL DRUG DISCOVERY MARKET BY TECHNOLOGY

5.1. MARKET DEFINITION AND SCOPE

5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

5.4. OPPORTUNITY MATRIX

5.5. MARKET SEGMENTATION

5.5.1.        GLOBAL HIGH THROUGHPUT SCREENING MARKET

5.5.1.1.               ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.1.2.               MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

5.5.1.3.               KEY PLAYERS & KEY PRODUCTS

5.5.1.4.               KEY CONCLUSIONS

5.5.2.      GLOBAL BIOCHIPS MARKET

5.5.2.1.               ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.2.2.               MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

5.5.2.3.               KEY PLAYERS & KEY PRODUCTS

5.5.2.4.               KEY CONCLUSIONS

5.5.3.      GLOBAL BIOINFORMATICS MARKET

5.5.3.1.               ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.3.2.               MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

5.5.3.3.               KEY PLAYERS & KEY PRODUCTS

5.5.3.4.               KEY CONCLUSIONS

5.5.4.      GLOBAL PHARMACOGENOMICS AND PHARMACOGENETICS MARKET

5.5.4.1.               ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.4.2.               MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

5.5.4.3.               KEY PLAYERS & KEY PRODUCTS

5.5.4.4.               KEY CONCLUSIONS

5.5.5.      GLOBAL COMBINATORIAL CHEMISTRY MARKET

5.5.5.1.               ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.5.2.               MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

5.5.5.3.               KEY PLAYERS & KEY PRODUCTS

5.5.5.4.               KEY CONCLUSIONS

5.5.6.      GLOBAL NANOTECHNOLOGY MARKET

5.5.6.1.               ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.6.2.               MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

5.5.6.3.               KEY PLAYERS & KEY PRODUCTS

5.5.6.4.               KEY CONCLUSIONS

5.5.7.      GLOBAL SPECTROSCOPY MARKET

5.5.7.1.               ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.7.2.               MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

5.5.7.3.               KEY PLAYERS & KEY PRODUCTS

5.5.7.4.               KEY CONCLUSIONS

5.5.8.      GLOBAL METABOLOMICS MARKET

5.5.8.1.               ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.8.2.               MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

5.5.8.3.               KEY PLAYERS & KEY PRODUCTS

5.5.8.4.               KEY CONCLUSIONS

5.5.9.      GLOBAL OTHER TECHNOLOGIES MARKET

5.5.9.1.               ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.9.2.               MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

5.5.9.3.               KEY PLAYERS & KEY PRODUCTS

5.5.9.4.               KEY CONCLUSIONS

6.       GLOBAL DRUG DISCOVERY MARKET BY SERVICE

6.1. MARKET DEFINITION AND SCOPE

6.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

6.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

6.4. OPPORTUNITY MATRIX

6.5. MARKET SEGMENTATION

6.5.1.        GLOBAL DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES MARKET

6.5.1.1.               ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.1.2.               MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

6.5.1.3.               KEY PLAYERS & KEY PRODUCTS

6.5.1.4.               KEY CONCLUSIONS

6.5.2.      GLOBAL PHARMACEUTICAL SERVICES MARKET

6.5.2.1.               ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.2.2.               MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

6.5.2.3.               KEY PLAYERS & KEY PRODUCTS

6.5.2.4.               KEY CONCLUSIONS

6.5.3.      GLOBAL CHEMICAL SERVICES MARKET

6.5.3.1.               ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.3.2.               MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

6.5.3.3.               KEY PLAYERS & KEY PRODUCTS

6.5.3.4.               KEY CONCLUSIONS

6.5.4.      GLOBAL BIOLOGICAL SERVICES MARKET

6.5.4.1.               ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.4.2.               MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

6.5.4.3.               KEY PLAYERS & KEY PRODUCTS

6.5.4.4.               KEY CONCLUSIONS

7.       GLOBAL DRUG DISCOVERY MARKET BY END USER

7.1. MARKET DEFINITION AND SCOPE

7.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

7.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

7.4. OPPORTUNITY MATRIX

7.5. MARKET SEGMENTATION

7.5.1.        GLOBAL RESEARCH INSTITUTES MARKET

7.5.1.1.               ADOPTION SCENARIO & MARKET DETERMINANTS

7.5.1.2.               MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

7.5.1.3.               KEY PLAYERS & KEY PRODUCTS

7.5.1.4.               KEY CONCLUSIONS

7.5.2.      GLOBAL PHARMACEUTICAL COMPANIES MARKET

7.5.2.1.               ADOPTION SCENARIO & MARKET DETERMINANTS

7.5.2.2.               MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

7.5.2.3.               KEY PLAYERS & KEY PRODUCTS

7.5.2.4.               KEY CONCLUSIONS

7.5.3.      GLOBAL BIOTECHNOLOGY COMPANIES MARKET

7.5.3.1.               ADOPTION SCENARIO & MARKET DETERMINANTS

7.5.3.2.               MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

7.5.3.3.               KEY PLAYERS & KEY PRODUCTS

7.5.3.4.               KEY CONCLUSIONS

7.5.4.      GLOBAL OTHER END USERS MARKET

7.5.4.1.               ADOPTION SCENARIO & MARKET DETERMINANTS

7.5.4.2.               MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

7.5.4.3.               KEY PLAYERS & KEY PRODUCTS

7.5.4.4.               KEY CONCLUSIONS

8.       COMPETITIVE LANDSCAPE

8.1. KEY STRATEGIES

8.1.1.        LIST OF MERGER & ACQUISITION

8.1.2.        LIST OF JOINT VENTURE

8.1.3.        LIST OF PRODUCT LAUNCHES

8.1.4.        LIST OF PARTNERSHIP

9.       GEOGRAPHIC ANALYSIS

9.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

9.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

9.3. OPPORTUNITY MATRIX

9.4.  GLOBAL DRUG DISCOVERYMARKET BY REGION 2015-2024($ MILLION)

9.4.1.      NORTH AMERICA

9.4.1.1.               INDUSTRY ANALYSIS 2015-2024($ MILLION)

9.4.1.2.               TOP COUNTRY ANALYSIS

9.4.1.2.1.        U.S.

9.4.1.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

9.4.1.2.1.2.   KEY PLAYERS & KEY PRODUCTS

9.4.1.2.1.3.   KEY CONCLUSIONS

9.4.1.2.2.        CANADA

9.4.1.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

9.4.1.2.2.2.   KEY PLAYERS & KEY PRODUCTS

9.4.1.2.2.3.   KEY CONCLUSIONS

9.4.2.      EUROPE

9.4.2.1.               INDUSTRY ANALYSIS 2015-2024($ MILLION)

9.4.2.2.               TOP COUNTRY ANALYSIS

9.4.2.2.1.        UK

9.4.2.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

9.4.2.2.1.2.   KEY PLAYERS & KEY PRODUCTS

9.4.2.2.1.3.   KEY CONCLUSIONS

9.4.2.2.2.        FRANCE

9.4.2.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

9.4.2.2.2.2.   KEY PLAYERS & KEY PRODUCTS

9.4.2.2.2.3.   KEY CONCLUSIONS

9.4.2.2.3.        GERMANY

9.4.2.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

9.4.2.2.3.2.   KEY PLAYERS & KEY PRODUCTS

9.4.2.2.3.3.   KEY CONCLUSIONS

9.4.2.2.4.        RUSSIA

9.4.2.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

9.4.2.2.4.2.   KEY PLAYERS & KEY PRODUCTS

9.4.2.2.4.3.   KEY CONCLUSIONS

9.4.2.2.5.        REST OF EUROPE

9.4.2.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

9.4.2.2.5.2.   KEY PLAYERS & KEY PRODUCTS

9.4.2.2.5.3.   KEY CONCLUSIONS

9.4.3.      ASIA PACIFIC

9.4.3.1.               INDUSTRY ANALYSIS 2015-2024($ MILLION)

9.4.3.2.               TOP COUNTRY ANALYSIS

9.4.3.2.1.        CHINA

9.4.3.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

9.4.3.2.1.2.   KEY PLAYERS & KEY PRODUCTS

9.4.3.2.1.3.   KEY CONCLUSIONS

9.4.3.2.2.        INDIA

9.4.3.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

9.4.3.2.2.2.   KEY PLAYERS & KEY PRODUCTS

9.4.3.2.2.3.   KEY CONCLUSIONS

9.4.3.2.3.        JAPAN

9.4.3.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

9.4.3.2.3.2.   KEY PLAYERS & KEY PRODUCTS

9.4.3.2.3.3.   KEY CONCLUSIONS

9.4.3.2.4.        AUSTRALIA

9.4.3.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

9.4.3.2.4.2.   KEY PLAYERS & KEY PRODUCTS

9.4.3.2.4.3.   KEY CONCLUSIONS

9.4.3.2.5.        REST OF ASIA PACIFIC

9.4.3.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

9.4.3.2.5.2.   KEY PLAYERS & KEY PRODUCTS

9.4.3.2.5.3.   KEY CONCLUSIONS

9.4.4.      ROW

9.4.4.1.               INDUSTRY ANALYSIS 2015-2024($ MILLION)

9.4.4.2.               TOP COUNTRY ANALYSIS

9.4.4.2.1.        LATIN AMERICA

9.4.4.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

9.4.4.2.1.2.   KEY PLAYERS & KEY PRODUCTS

9.4.4.2.1.3.   KEY CONCLUSIONS

9.4.4.2.2.        MIDDLE EAST & AFRICA

9.4.4.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024($ MILLION)

9.4.4.2.2.2.   KEY PLAYERS & KEY PRODUCTS

9.4.4.2.2.3.   KEY CONCLUSIONS

10.   COMPANY PROFILES

10.1.         ASTRAZENECA (U.K)

10.1.1.   OVERVIEW

10.1.2.   PRODUCT PORTFOLIO

10.1.3.   STRATEGIC INITIATIVES

10.1.4.   SCOT ANALYSIS

10.1.5.   STRATEGIC ANALYSIS

10.2.         ALBANY MOLECULER RESEARCH (U.S.)

10.2.1.   OVERVIEW

10.2.2.   PRODUCT PORTFOLIO

10.2.3.   STRATEGIC INITIATIVES

10.2.4.   SCOT ANALYSIS

10.2.5.   STRATEGIC ANALYSIS

10.3.         BAYER (GERMANY)

10.3.1.   OVERVIEW

10.3.2.   PRODUCT PORTFOLIO

10.3.3.   STRATEGIC INITIATIVES

10.3.4.   SCOT ANALYSIS

10.3.5.   STRATEGIC ANALYSIS

10.4.         BOEHRINGER INGELHEIM (GERMANY)

10.4.1.   OVERVIEW

10.4.2.   PRODUCT PORTFOLIO

10.4.3.   STRATEGIC INITIATIVES

10.4.4.   SCOT ANALYSIS

10.4.5.   STRATEGIC ANALYSIS

10.5.         COVANCE. (U.S.)

10.5.1.   OVERVIEW

10.5.2.   PRODUCT PORTFOLIO

10.5.3.   STRATEGIC INITIATIVES

10.5.4.   SCOT ANALYSIS

10.5.5.   STRATEGIC ANALYSIS

10.6.         CYPROTEX. (U.K.)

10.6.1.   OVERVIEW

10.6.2.   PRODUCT PORTFOLIO

10.6.3.   STRATEGIC INITIATIVES

10.6.4.   SCOT ANALYSIS

10.6.5.   STRATEGIC ANALYSIS

10.7.         ELI LILY (U.S)

10.7.1.   OVERVIEW

10.7.2.   PRODUCT PORTFOLIO

10.7.3.   STRATEGIC INITIATIVES

10.7.4.   SCOT ANALYSIS

10.7.5.   STRATEGIC ANALYSIS

10.8.         GLAXOSMITHKLINE PLC (UK)

10.8.1.   OVERVIEW

10.8.2.   PRODUCT PORTFOLIO

10.8.3.   STRATEGIC INITIATIVES

10.8.4.   SCOT ANALYSIS

10.8.5.   STRATEGIC ANALYSIS

10.9.         GENSCRIPT (U.S)

10.9.1.   OVERVIEW

10.9.2.   PRODUCT PORTFOLIO

10.9.3.   STRATEGIC INITIATIVES

10.9.4.   SCOT ANALYSIS

10.9.5.   STRATEGIC ANALYSIS

10.10.     JOHNSON AND JOHNSON (U.S)

10.10.1.              OVERVIEW

10.10.2.              PRODUCT PORTFOLIO

10.10.3.              STRATEGIC INITIATIVES

10.10.4.              SCOT ANALYSIS

10.10.5.              STRATEGIC ANALYSIS

10.11.     PFIZER, INC. (U.S.)

10.11.1.              OVERVIEW

10.11.2.              PRODUCT PORTFOLIO

10.11.3.              STRATEGIC INITIATIVES

10.11.4.              SCOT ANALYSIS

10.11.5.              STRATEGIC ANALYSIS

10.12.     QUINTILES (U.S)

10.12.1.              OVERVIEW

10.12.2.              PRODUCT PORTFOLIO

10.12.3.              STRATEGIC INITIATIVES

10.12.4.              SCOT ANALYSIS

10.12.5.              STRATEGIC ANALYSIS

10.13.     VIVA BIOTECH (CHINA)

10.13.1.              OVERVIEW

10.13.2.              PRODUCT PORTFOLIO

10.13.3.              STRATEGIC INITIATIVES

10.13.4.              SCOT ANALYSIS

10.13.5.              STRATEGIC ANALYSIS

10.14.     WIL RESEARCH LABORATORIES (U.S.)

10.14.1.              OVERVIEW

10.14.2.              PRODUCT PORTFOLIO

10.14.3.              STRATEGIC INITIATIVES

10.14.4.              SCOT ANALYSIS

10.14.5.              STRATEGIC ANALYSIS

10.15.     WUXI APPTECH (CHINA)

10.15.1.              OVERVIEW

10.15.2.              PRODUCT PORTFOLIO

10.15.3.              STRATEGIC INITIATIVES

10.15.4.              SCOT ANALYSIS

10.15.5.              STRATEGIC ANALYSIS

 

LIST OF TABLES

1.       GLOBAL DRUG DISCOVERY MARKET BY DRUG TYPE 2015-2024($ MILLION)

2.       GLOBAL SMALL MOLECULE DRUG MARKET BY GEOGRAPHY 2015-2024($ MILLION)

3.       GLOBAL BIOLOGICS DRUG MARKET BY GEOGRAPHY 2015-2024($ MILLION)

4.       GLOBAL DRUG DISCOVERY MARKET BY TECHNOLOGY 2015-2024($ MILLION)

5.       GLOBAL HIGH THROUGHPUT SCREENING MARKET BY GEOGRAPHY 2015-2024($ MILLION)

6.       GLOBAL BIOCHIPS MARKET BY GEOGRAPHY 2015-2024($ MILLION)

7.       GLOBAL BIOINFORMATICS MARKET BY GEOGRAPHY 2015-2024($ MILLION)

8.       GLOBAL PHARMACOGENOMICS AND PHARMACOGENETICS MARKET BY GEOGRAPHY 2015-2024($ MILLION)

9.       GLOBAL COMBINATORIAL CHEMISTRY MARKET BY GEOGRAPHY 2015-2024($ MILLION)

10.   GLOBAL NANOTECHNOLOGY MARKET BY GEOGRAPHY 2015-2024($ MILLION)

11.   GLOBAL SPECTROSCOPY MARKET BY GEOGRAPHY 2015-2024($ MILLION)

12.   GLOBAL METABOLOMICS MARKET BY GEOGRAPHY 2015-2024($ MILLION)

13.   GLOBAL OTHER TECHNOLOGIES MARKET BY GEOGRAPHY 2015-2024($ MILLION)

14.   GLOBAL DRUG DISCOVERY MARKET BY SERVICE 2015-2024($ MILLION)

15.   GLOBAL DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES MARKET BY GEOGRAPHY 2015-2024($ MILLION)

16.   GLOBAL PHARMACEUTICAL SERVICES MARKET BY GEOGRAPHY 2015-2024($ MILLION)

17.   GLOBAL CHEMICAL SERVICES MARKET BY GEOGRAPHY 2015-2024($ MILLION)

18.   GLOBAL BIOLOGICAL SERVICES MARKET BY GEOGRAPHY 2015-2024($ MILLION)

19.   GLOBAL DRUG DISCOVERY MARKET BY END USER 2015-2024($ MILLION)

20.   GLOBAL RESEARCH INSTITUTES MARKET BY GEOGRAPHY 2015-2024($ MILLION)

21.   GLOBAL PHARMACEUTICAL COMPANIES MARKET BY GEOGRAPHY 2015-2024($ MILLION)

22.   GLOBAL BIOTECHNOLOGY COMPANIES MARKET BY GEOGRAPHY 2015-2024($ MILLION)

23.   GLOBAL OTHER END USERS MARKET BY GEOGRAPHY 2015-2024($ MILLION)

24.   NORTH AMERICA DRUG DISCOVERY MARKET 2015-2024($ MILLION)

25.   EUROPE DRUG DISCOVERY MARKET 2015-2024($ MILLION)

26.   ASIA PACIFIC DRUG DISCOVERY MARKET 2015-2024($ MILLION)

27.   REST OF THE WORLD DRUG DISCOVERY MARKET 2015-2024($ MILLION)

28.   NORTH AMERICA DRUG DISCOVERY MARKET BY DRUG TYPE 2015-2024($ MILLION)

29.   EUROPE DRUG DISCOVERY MARKET BY DRUG TYPE 2015-2024($ MILLION)

30.   ASIA PACIFIC DRUG DISCOVERYMARKET  BY DRUG TYPE 2015-2024($ MILLION)

31.   REST OF THE WORLD DRUG DISCOVERYMARKET BY DRUG TYPE 2015-2024($ MILLION)

32.   NORTH AMERICA DRUG DISCOVERYMARKET BY TECHNOLOGY 2015-2024($ MILLION)

33.   EUROPE DRUG DISCOVERYMARKET BY TECHNOLOGY 2015-2024($ MILLION)

34.   ASIA PACIFIC DRUG DISCOVERYMARKET  BY TECHNOLOGY 2015-2024($ MILLION)

35.   REST OF THE WORLD DRUG DISCOVERYMARKET BY TECHNOLOGY 2015-2024($ MILLION)

36.   NORTH AMERICA DRUG DISCOVERYMARKET BY SERVICE  2015-2024($ MILLION)

37.   EUROPE DRUG DISCOVERYMARKET BY SERVICE2015-2024($ MILLION)

38.   ASIA PACIFIC DRUG DISCOVERYMARKET  BY SERVICE 2015-2024($ MILLION)

39.   REST OF THE WORLD DRUG DISCOVERYMARKET BY SERVICE 2015-2024($ MILLION)

40.   UNITED STATES GLOBAL DRUG DISCOVERYBY DRUG TYPE 2015-2024($ MILLION)

41.   UNITED STATES GLOBAL DRUG DISCOVERYBY TECHNOLOGY 2015-2024($ MILLION)

42.   UNITED STATES GLOBAL DRUG DISCOVERYBY SERVICE 2015-2024($ MILLION)

43.   UNITED STATES GLOBAL DRUG DISCOVERY BY END USER 2015-2024($ MILLION)

44.   CANADA GLOBAL DRUG DISCOVERYBY DRUG TYPE 2015-2024($ MILLION)

45.   CANADA GLOBAL DRUG DISCOVERYBY TECHNOLOGY 2015-2024($ MILLION)

46.   CANADA GLOBAL DRUG DISCOVERYBY SERVICE 2015-2024($ MILLION)

47.   CANADA GLOBAL DRUG DISCOVERYBY END USER 2015-2024($ MILLION)

48.   UK GLOBAL DRUG DISCOVERYBY DRUG TYPE 2015-2024($ MILLION)

49.   UK GLOBAL DRUG DISCOVERYBY TECHNOLOGY 2015-2024($ MILLION)

50.   UK GLOBAL DRUG DISCOVERYBY SERVICE 2015-2024($ MILLION)

51.   UK GLOBAL DRUG DISCOVERYBY END USER 2015-2024($ MILLION)

52.   GERMANY GLOBAL DRUG DISCOVERY BY DRUG TYPE 2015-2024($ MILLION)

53.   GERMANY GLOBAL DRUG DISCOVERY BY TECHNOLOGY 2015-2024($ MILLION)

54.   GERMANY GLOBAL DRUG DISCOVERYBY SERVICE 2015-2024($ MILLION)

55.   GERMANY GLOBAL DRUG DISCOVERYBY END USER 2015-2024($ MILLION)

56.   FRANCE GLOBAL DRUG DISCOVERYBY DRUG TYPE 2015-2024($ MILLION)

57.   FRANCE GLOBAL DRUG DISCOVERYBY TECHNOLOGY 2015-2024($ MILLION)

58.   FRANCE GLOBAL DRUG DISCOVERYBY SERVICE 2015-2024($ MILLION)

59.   FRANCE GLOBAL DRUG DISCOVERYBY END USER 2015-2024($ MILLION)

60.   SPAIN GLOBAL DRUG DISCOVERY BY DRUG TYPE 2015-2024($ MILLION)

61.   SPAIN GLOBAL DRUG DISCOVERY BY TECHNOLOGY 2015-2024($ MILLION)

62.   SPAIN GLOBAL DRUG DISCOVERY  BY SERVICE 2015-2024($ MILLION)

63.   SPAIN GLOBAL DRUG DISCOVERYBY END USER 2015-2024($ MILLION)

64.   ROE GLOBAL DRUG DISCOVERYBY DRUG TYPE 2015-2024($ MILLION)

65.   ROE GLOBAL DRUG DISCOVERYBY TECHNOLOGY 2015-2024($ MILLION)

66.   ROE GLOBAL DRUG DISCOVERYBY SERVICE 2015-2024($ MILLION)

67.   ROE GLOBAL DRUG DISCOVERYBY END USER TYPE 2015-2024($ MILLION)

68.   INDIA GLOBAL DRUG DISCOVERYBY DRUG TYPE 2015-2024($ MILLION)

69.   INDIA GLOBAL DRUG DISCOVERY TECHNOLOGY 2015-2024($ MILLION)

70.   INDIA GLOBAL DRUG DISCOVERYBY SERVICE 2015-2024($ MILLION)

71.   INDIA GLOBAL DRUG DISCOVERYBY END USER 2015-2024($ MILLION)

72.   CHINA GLOBAL DRUG DISCOVERYBY DRUG TYPE 2015-2024($ MILLION)

73.   CHINA GLOBAL DRUG DISCOVERYBY TECHNOLOGY 2015-2024($ MILLION)

74.   CHINA GLOBAL DRUG DISCOVERYBY SERVICE 2015-2024($ MILLION)

75.   CHINA GLOBAL DRUG DISCOVERYBY END USER 2015-2024($ MILLION)

76.   JAPAN GLOBAL DRUG DISCOVERYBY DRUG TYPE 2015-2024($ MILLION)

77.   JAPAN GLOBAL DRUG DISCOVERYBY TECHNOLOGY 2015-2024($ MILLION)

78.   JAPAN GLOBAL DRUG DISCOVERYBY SERVICE 2015-2024($ MILLION)

79.   JAPAN GLOBAL DRUG DISCOVERYBY END USER 2015-2024($ MILLION)

80.   AUSTRALIA GLOBAL DRUG DISCOVERYBY DRUG TYPE 2015-2024($ MILLION)

81.   AUSTRALIA GLOBAL DRUG DISCOVERYBY TECHNOLOGY 2015-2024($ MILLION)

82.   AUSTRALIA GLOBAL DRUG DISCOVERYBY SERVICE 2015-2024($ MILLION)

83.   AUSTRALIA GLOBAL DRUG DISCOVERYBY END USER 2015-2024($ MILLION)

84.   ROAPAC GLOBAL DRUG DISCOVERYBY DRUG TYPE 2015-2024($ MILLION)

85.   ROAPAC GLOBAL DRUG DISCOVERYBY TECHNOLOGY 2015-2024($ MILLION)

86.   ROAPAC GLOBAL DRUG DISCOVERYBY SERVICE 2015-2024($ MILLION)

87.   ROAPAC GLOBAL DRUG DISCOVERYBY END USER 2015-2024($ MILLION)

88.   LATIN AMERICA GLOBAL DRUG DISCOVERYBY DRUG TYPE 2015-2024($ MILLION)

89.   LATIN AMERICA GLOBAL DRUG DISCOVERYBY TECHNOLOGY 2015-2024($ MILLION)

90.   LATIN AMERICA GLOBAL DRUG DISCOVERYBY SERVICE 2015-2024($ MILLION)

91.   LATIN AMERICA GLOBAL DRUG DISCOVERYBY END USER 2015-2024($ MILLION)

92.   MENA GLOBAL DRUG DISCOVERYBY DRUG TYPE 2015-2024($ MILLION)

93.   MENA GLOBAL DRUG DISCOVERYBY TECHNOLOGY 2015-2024($ MILLION)

94.   MENA GLOBAL DRUG DISCOVERYBY SERVICE 2015-2024($ MILLION)

95.   MENA GLOBAL DRUG DISCOVERYBY END USER 2015-2024($ MILLION)

LIST OF FIGURES

1.       GLOBAL DRUG DISCOVERY MARKET BY DRUG TYPE 2015-2024($ MILLION)

2.       GLOBAL SMALL MOLECULE DRUG MARKET BY GEOGRAPHY 2015-2024($ MILLION)

3.       GLOBAL BIOLOGICS DRUG MARKET BY GEOGRAPHY 2015-2024($ MILLION)

4.       GLOBAL DRUG DISCOVERY MARKET BY TECHNOLOGY 2015-2024($ MILLION)

5.       GLOBAL HIGH THROUGHPUT SCREENING MARKET BY GEOGRAPHY 2015-2024($ MILLION)

6.       GLOBAL BIOCHIPS MARKET BY GEOGRAPHY 2015-2024($ MILLION)

7.       GLOBAL BIOINFORMATICS MARKET BY GEOGRAPHY 2015-2024($ MILLION)

8.       GLOBAL PHARMACOGENOMICS AND PHARMACOGENETICS MARKET BY GEOGRAPHY 2015-2024($ MILLION)

9.       GLOBAL COMBINATORIAL CHEMISTRY MARKET BY GEOGRAPHY 2015-2024($ MILLION)

10.   GLOBAL NANOTECHNOLOGY MARKET BY GEOGRAPHY 2015-2024($ MILLION)

11.   GLOBAL SPECTROSCOPY MARKET BY GEOGRAPHY 2015-2024($ MILLION)

12.   GLOBAL METABOLOMICS MARKET BY GEOGRAPHY 2015-2024($ MILLION)

13.   GLOBAL OTHER TECHNOLOGIES MARKET BY GEOGRAPHY 2015-2024($ MILLION)

14.   GLOBAL DRUG DISCOVERY MARKET BY SERVICE 2015-2024($ MILLION)

15.   GLOBAL DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES MARKET BY GEOGRAPHY 2015-2024($ MILLION)

16.   GLOBAL PHARMACEUTICAL SERVICES MARKET BY GEOGRAPHY 2015-2024($ MILLION)

17.   GLOBAL CHEMICAL SERVICES MARKET BY GEOGRAPHY 2015-2024($ MILLION)

18.   GLOBAL BIOLOGICAL SERVICES MARKET BY GEOGRAPHY 2015-2024($ MILLION)

19.   GLOBAL DRUG DISCOVERY MARKET BY END USER 2015-2024($ MILLION)

20.   GLOBAL RESEARCH INSTITUTES MARKET BY GEOGRAPHY 2015-2024($ MILLION)

21.   GLOBAL PHARMACEUTICAL COMPANIES MARKET BY GEOGRAPHY 2015-2024($ MILLION)

22.   GLOBAL BIOTECHNOLOGY COMPANIES MARKET BY GEOGRAPHY 2015-2024($ MILLION)

23.   GLOBAL OTHER END USERS MARKET BY GEOGRAPHY 2015-2024($ MILLION)

24.   UNITED STATES (U.S.) DRUG DISCOVERYMARKET 2015-2024($ MILLION)

25.   CANADA DRUG DISCOVERYMARKET 2015-2024($ MILLION)

26.   UNITED KINGDOM (UK) DRUG DISCOVERYMARKET 2015-2024($ MILLION)

27.   FRANCE DRUG DISCOVERYMARKET 2015-2024($ MILLION)

28.   GERMANY DRUG DISCOVERYMARKET 2015-2024($ MILLION)

29.   RUSSIA DRUG DISCOVERYMARKET 2015-2024($ MILLION)

30.   ROE DRUG DISCOVERYMARKET 2015-2024($ MILLION)

31.   INDIA DRUG DISCOVERYMARKET 2015-2024($ MILLION)

32.   CHINA DRUG DISCOVERYMARKET 2015-2024($ MILLION)

33.   JAPAN DRUG DISCOVERYMARKET 2015-2024($ MILLION)

34.   AUSTRALIA DRUG DISCOVERYMARKET 2015-2024($ MILLION)

35.   ROAPAC DRUG DISCOVERYMARKET 2015-2024($ MILLION)

36.   LATIN AMERICA DRUG DISCOVERYMARKET 2015-2024($ MILLION)

37.   MENA DRUG DISCOVERYMARKET 2015-2024($ MILLION)

 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.